{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T10:41:48Z","timestamp":1793788908646,"version":"4.6.1"},"reference-count":72,"publisher":"American Medical Association (AMA)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Cardiol"],"published-print":{"date-parts":[[2024,11,1]]},"abstract":"\n Importance<\/jats:title>\n The epidemiological link between immune-mediated diseases (IMIDs) and cardiovascular disease has often been attributed to systemic inflammation. However, the direction of causality and the biological mechanisms linking cardiovascular disease with IMIDs are incompletely understood. Given the robust epidemiological association and the growing body of supportive mechanistic evidence, psoriasis is an exemplary IMID model for exploring this relationship.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n To assess the bidirectional relationships between genetic predictors of psoriasis and the 2 major forms of cardiovascular disease, coronary artery disease (CAD) and stroke, and to evaluate the association between genetic predictors of cardiovascular disease with 9 other IMIDs.<\/jats:p>\n <\/jats:sec>\n \n Design, Setting, and Participants<\/jats:title>\n This was a genetic association study using mendelian randomization (MR), a powerful genetic tool to help distinguish causation from associations observed in epidemiological studies, to provide supportive evidence for causality between traits. The study conducted 2-sample MR analyses using summary-level data from large-scale genome-wide association meta-analysis studies (GWAS) for each trait. The analysis focused on individuals of European descent from GWAS meta-analyses, involving CAD, stroke, psoriasis, and 9 other IMIDs. Data were analyzed from January 2023 to May 2024.<\/jats:p>\n <\/jats:sec>\n \n Exposures<\/jats:title>\n Genetic predictors of CAD, stroke, psoriasis, and 9 other IMIDs.<\/jats:p>\n <\/jats:sec>\n \n Main Outcomes and Measures<\/jats:title>\n The primary outcomes were the associations of genetic predictors of CAD and stroke with the risk of psoriasis and 9 other IMIDs, determined using inverse-variance weighted (IVW) MR estimates.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n \n This study included 181\u202f249 cases and 1\u202f165\u202f690 controls with CAD, 110\u202f182 cases and 1\u202f503\u202f898 controls with stroke, 36\u202f466 cases and 458\u202f078 controls with psoriasis, for a total of approximately 3\u202f400\u202f000 individuals, and 9 other IMIDs. In contrast to previous assumptions, genetic predictors of psoriasis were found to have no association with CAD or stroke. In the reverse direction, genetic predictors of both CAD (MR estimate IVW odds ratio [OR], 1.07; 95% CI, 1.04-1.10;\n P<\/jats:italic>\n \u2009=\u2009.003) and stroke (IVW OR, 1.22; 95% CI, 1.05-1.41;\n P<\/jats:italic>\n \u2009=\u2009.01) were found to have risk-increasing associations with psoriasis. Adjusting for stroke rendered the associations of genetically predicted CAD with psoriasis risk nonsignificant (and vice versa), suggesting that a shared effect underlying genetic risk for CAD and stroke associates with increased psoriasis risk. No risk-increasing associations were observed for genetic predictors of cardiovascular disease with other common IMIDs, including rheumatoid arthritis and inflammatory bowel disease.\n <\/jats:p>\n <\/jats:sec>\n \n Conclusions and Relevance<\/jats:title>\n Findings of this mendelian randomization study indicate that genetic predictors of cardiovascular disease were associated with increased psoriasis risk with no reciprocal effect or association with other IMIDs. Elucidating mechanisms underpinning this association could lead to novel therapeutic approaches in both diseases.<\/jats:p>\n <\/jats:sec>","DOI":"10.1001\/jamacardio.2024.2859","type":"journal-article","created":{"date-parts":[[2024,9,18]],"date-time":"2024-09-18T11:01:19Z","timestamp":1726657279000},"page":"1009","source":"Crossref","is-referenced-by-count":31,"title":["Exploring the Link Between Genetic Predictors of Cardiovascular Disease and Psoriasis"],"prefix":"10.1001","volume":"9","author":[{"given":"Ravi","family":"Ramessur","sequence":"first","affiliation":[{"name":"St John\u2019s Institute of Dermatology, School of Basic & Medical Biosciences, Faculty of Life Sciences & Medicine, King\u2019s College London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jake","family":"Saklatvala","sequence":"additional","affiliation":[{"name":"Department of Medical and Molecular Genetics, School of Basic & Medical Biosciences, King\u2019s College London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley","family":"Budu-Aggrey","sequence":"additional","affiliation":[{"name":"MRC Integrative Epidemiology Unit at University of Bristol, Bristol, United Kingdom"},{"name":"Population Health Sciences, Bristol Medical School, Bristol, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marek","family":"Ostaszewski","sequence":"additional","affiliation":[{"name":"Luxembourg Centre for Systems Biomedicine, University of Luxembourg, Esch-sur-Alzette, Luxembourg"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lena","family":"M\u00f6bus","sequence":"additional","affiliation":[{"name":"Finnish Hub for Development and Validation of Integrated Approaches, Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dario","family":"Greco","sequence":"additional","affiliation":[{"name":"Finnish Hub for Development and Validation of Integrated Approaches, Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland"},{"name":"Division of Pharmaceutical Biosciences, Faculty of Pharmacy, University of Helsinki, Helsinki, Uusimaa, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matladi","family":"Ndlovu","sequence":"additional","affiliation":[{"name":"Department of Immunology Research, UCB, Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satveer K.","family":"Mahil","sequence":"additional","affiliation":[{"name":"St John\u2019s Institute of Dermatology, School of Basic & Medical Biosciences, Faculty of Life Sciences & Medicine, King\u2019s College London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan N.","family":"Barker","sequence":"additional","affiliation":[{"name":"St John\u2019s Institute of Dermatology, School of Basic & Medical Biosciences, Faculty of Life Sciences & Medicine, King\u2019s College London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Brown","sequence":"additional","affiliation":[{"name":"Centre for Genomic and Experimental Medicine, University of Edinburgh, Edinburgh, Scotland, United Kingdom"},{"name":"Department of Dermatology, NHS Lothian, Edinburgh, Scotland, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lavinia","family":"Paternoster","sequence":"additional","affiliation":[{"name":"MRC Integrative Epidemiology Unit at University of Bristol, Bristol, United Kingdom"},{"name":"Population Health Sciences, Bristol Medical School, Bristol, United Kingdom"},{"name":"NIHR Bristol Biomedical Research Centre, University Hospitals Bristol and Weston NHS Foundation Trust and University of Bristol, Bristol, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nick","family":"Dand","sequence":"additional","affiliation":[{"name":"Department of Medical and Molecular Genetics, School of Basic & Medical Biosciences, King\u2019s College London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Simpson","sequence":"additional","affiliation":[{"name":"Department of Medical and Molecular Genetics, School of Basic & Medical Biosciences, King\u2019s College London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine H.","family":"Smith","sequence":"additional","affiliation":[{"name":"St John\u2019s Institute of Dermatology, School of Basic & Medical Biosciences, Faculty of Life Sciences & Medicine, King\u2019s College London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"7855","key":"hoi240051r1","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1038\/s41586-021-03392-8","article-title":"The changing landscape of atherosclerosis.","volume":"592","author":"Libby","year":"2021","journal-title":"Nature"},{"issue":"1","key":"hoi240051r2","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s12872-022-02525-9","article-title":"Safety and efficacy of anti-inflammatory therapy in patients with coronary artery disease: a systematic review and meta-analysis.","volume":"22","author":"Niu","year":"2022","journal-title":"BMC Cardiovasc Disord"},{"issue":"19","key":"hoi240051r3","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.1056\/NEJMoa2021372","article-title":"Colchicine in patients with chronic coronary disease.","volume":"383","author":"Nidorf","year":"2020","journal-title":"N Engl J Med"},{"issue":"12","key":"hoi240051r4","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Anti-inflammatory therapy with canakinumab for atherosclerotic disease.","volume":"377","author":"Ridker","year":"2017","journal-title":"N Engl J Med"},{"issue":"8","key":"hoi240051r5","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1056\/NEJMoa1809798","article-title":"Low-dose methotrexate for the prevention of atherosclerotic events.","volume":"380","author":"Ridker","year":"2019","journal-title":"N Engl J Med"},{"issue":"16","key":"hoi240051r6","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1016\/j.jacc.2012.07.019","article-title":"CD14++CD16+ monocytes independently predict cardiovascular events: a cohort study of 951 patients referred for elective coronary angiography.","volume":"60","author":"Rogacev","year":"2012","journal-title":"J Am Coll Cardiol"},{"issue":"46","key":"hoi240051r7","doi-asserted-by":"publisher","first-page":"4109","DOI":"10.1093\/eurheartj\/ehy723","article-title":"Has the time finally come to measure hsCRP universally in primary and secondary cardiovascular prevention?","volume":"39","author":"Ridker","year":"2018","journal-title":"Eur Heart J"},{"issue":"12","key":"hoi240051r8","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1002\/art.24092","article-title":"Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies.","volume":"59","author":"Avi\u00f1a-Zubieta","year":"2008","journal-title":"Arthritis Rheum"},{"issue":"6","key":"hoi240051r9","doi-asserted-by":"publisher","first-page":"409","DOI":"10.7326\/M14-2470","article-title":"Patients with ankylosing spondylitis have increased cardiovascular and cerebrovascular mortality: a population-based study.","volume":"163","author":"Haroon","year":"2015","journal-title":"Ann Intern Med"},{"issue":"8","key":"hoi240051r10","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.117.005892","article-title":"Inflammatory bowel disease and risk of ischemic heart disease: an updated meta-analysis of cohort studies.","volume":"6","author":"Feng","year":"2017","journal-title":"J Am Heart Assoc"},{"issue":"2","key":"hoi240051r11","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1136\/annrheumdis-2014-205675","article-title":"Risk of major cardiovascular events in patients with psoriatic arthritis, psoriasis and rheumatoid arthritis: a population-based cohort study.","volume":"74","author":"Ogdie","year":"2015","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"hoi240051r12","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1093\/rheumatology\/kead266","article-title":"Immune-mediated diseases and risk of incident cardiovascular diseases: a prospective cohort study.","volume":"63","author":"Yu","year":"2024","journal-title":"Rheumatology (Oxford)"},{"issue":"10354","key":"hoi240051r13","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/S0140-6736(22)01349-6","article-title":"Autoimmune diseases and cardiovascular risk: a population-based study on 19 autoimmune diseases and 12 cardiovascular diseases in 22 million individuals in the UK.","volume":"400","author":"Conrad","year":"2022","journal-title":"Lancet"},{"issue":"2","key":"hoi240051r14","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1136\/heartjnl-2017-311279","article-title":"Association between chronic immune-mediated inflammatory diseases and cardiovascular risk.","volume":"104","author":"Baena-D\u00edez","year":"2018","journal-title":"Heart"},{"issue":"10281","key":"hoi240051r15","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1016\/S0140-6736(20)32549-6","article-title":"Psoriasis.","volume":"397","author":"Griffiths","year":"2021","journal-title":"Lancet"},{"issue":"10","key":"hoi240051r16","doi-asserted-by":"publisher","first-page":"2411","DOI":"10.1038\/jid.2009.112","article-title":"The risk of stroke in patients with psoriasis.","volume":"129","author":"Gelfand","year":"2009","journal-title":"J Invest Dermatol"},{"issue":"14","key":"hoi240051r17","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1001\/jama.296.14.1735","article-title":"Risk of myocardial infarction in patients with psoriasis.","volume":"296","author":"Gelfand","year":"2006","journal-title":"JAMA"},{"issue":"11","key":"hoi240051r18","doi-asserted-by":"publisher","first-page":"e596","DOI":"10.1161\/CIR.0000000000000678","article-title":"2019 ACC\/AHA guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology\/American Heart Association task force on clinical practice guidelines.","volume":"140","author":"Arnett","year":"2019","journal-title":"Circulation"},{"issue":"13","key":"hoi240051r19","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1016\/j.jacc.2021.02.009","article-title":"Cardiovascular risk in patients with psoriasis: JACC review topic of the week.","volume":"77","author":"Garshick","year":"2021","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"hoi240051r20","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1161\/STROKEAHA.114.006516","article-title":"Interleukin 23 levels are increased in carotid atherosclerosis: possible role for the interleukin 23\/interleukin 17 axis.","volume":"46","author":"Abbas","year":"2015","journal-title":"Stroke"},{"issue":"2","key":"hoi240051r21","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.jaad.2018.02.040","article-title":"Interleukin 17, inflammation, and cardiovascular risk in patients with psoriasis.","volume":"79","author":"Lockshin","year":"2018","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"hoi240051r22","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/j.jid.2018.10.042","article-title":"Impact of secukinumab on endothelial dysfunction and other cardiovascular disease parameters in psoriasis patients over 52 weeks.","volume":"139","author":"von Stebut","year":"2019","journal-title":"J Invest Dermatol"},{"issue":"4","key":"hoi240051r23","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1093\/cvr\/cvz009","article-title":"Coronary artery plaque characteristics and treatment with biologic therapy in severe psoriasis: results from a prospective observational study.","volume":"115","author":"Elnabawi","year":"2019","journal-title":"Cardiovasc Res"},{"issue":"2","key":"hoi240051r24","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.2195","article-title":"Psoriasis and cardiovascular diseases: a literature review to determine the causal relationship.","volume":"10","author":"Jindal","year":"2018","journal-title":"Cureus"},{"key":"hoi240051r25","doi-asserted-by":"publisher","first-page":"186","DOI":"10.12688\/wellcomeopenres.15555.3","article-title":"Guidelines for performing mendelian randomization investigations: update for summer 2023.","volume":"4","author":"Burgess","year":"2023","journal-title":"Wellcome Open Res"},{"issue":"1","key":"hoi240051r26","doi-asserted-by":"publisher","first-page":"6565","DOI":"10.1038\/s41467-022-34323-4","article-title":"Shared genetic risk factors and causal association between psoriasis and coronary artery disease.","volume":"13","author":"Patrick","year":"2022","journal-title":"Nat Commun"},{"issue":"1","key":"hoi240051r27","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1186\/s12916-022-02617-5","article-title":"Psoriasis and cardiovascular disease risk in European and East Asian populations: evidence from meta-analysis and mendelian randomization analysis.","volume":"20","author":"Zhang","year":"2022","journal-title":"BMC Med"},{"issue":"3","key":"hoi240051r28","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1093\/rheumatology\/keac403","article-title":"Association between psoriatic disease and lifestyle factors and comorbidities: cross-sectional analysis and mendelian randomization.","volume":"62","author":"Zhao","year":"2023","journal-title":"Rheumatology (Oxford)"},{"issue":"7934","key":"hoi240051r29","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/s41586-022-05165-3","article-title":"Stroke genetics informs drug discovery and risk prediction across ancestries.","volume":"611","author":"Mishra","year":"2022","journal-title":"Nature"},{"issue":"12","key":"hoi240051r31","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1038\/s41588-022-01233-6","article-title":"Discovery and systematic characterization of risk variants and genes for coronary artery disease in over a million participants.","volume":"54","author":"Aragam","year":"2022","journal-title":"Nat Genet"},{"issue":"16","key":"hoi240051r32","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1001\/jama.2021.18236","article-title":"Strengthening the reporting of observational studies in epidemiology using mendelian randomization: the STROBE-MR statement.","volume":"326","author":"Skrivankova","year":"2021","journal-title":"JAMA"},{"issue":"1","key":"hoi240051r33","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1001\/jamacardio.2020.4317","article-title":"Expressing results from a mendelian randomization analysis: separating results from inferences.","volume":"6","author":"Burgess","year":"2021","journal-title":"JAMA Cardiol"},{"key":"hoi240051r34","doi-asserted-by":"publisher","DOI":"10.2340\/actadv.v103.5921","article-title":"Cardiovascular and metabolic profile of subjects with acne in a cohort of middle-aged patients: a general population study of 1932 subjects.","volume":"103","author":"Sinikumpu","year":"2023","journal-title":"Acta Derm Venereol"},{"issue":"5","key":"hoi240051r35","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1016\/j.jaci.2018.11.030","article-title":"Atopic eczema and major cardiovascular outcomes: a systematic review and meta-analysis of population-based studies.","volume":"143","author":"Ascott","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"hoi240051r36","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2022.861798","article-title":"Association between asthma and all-cause mortality and cardiovascular disease morbidity and mortality: a meta-analysis of cohort studies.","volume":"9","author":"Zhang","year":"2022","journal-title":"Front Cardiovasc Med"},{"issue":"10","key":"hoi240051r37","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/j.dld.2015.06.004","article-title":"Cardiovascular disease in patients with celiac disease: A systematic review and meta-analysis.","volume":"47","author":"Emilsson","year":"2015","journal-title":"Dig Liver Dis"},{"issue":"6","key":"hoi240051r38","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000032775","article-title":"Inflammatory bowel disease and associated cardiovascular disease outcomes: a systematic review.","volume":"102","author":"Jaiswal","year":"2023","journal-title":"Medicine (Baltimore)"},{"key":"hoi240051r39","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2021.103279","article-title":"Associations between multiple sclerosis and incidence of heart diseases: systematic review and meta-analysis of observational studies.","volume":"56","author":"Rapp","year":"2021","journal-title":"Mult Scler Relat Disord"},{"issue":"15","key":"hoi240051r40","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1177\/2047487318792952","article-title":"Inflammatory bowel disease and cardiovascular disease incidence and mortality: A meta-analysis.","volume":"25","author":"Sun","year":"2018","journal-title":"Eur J Prev Cardiol"},{"issue":"1","key":"hoi240051r41","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1038\/s41467-022-28252-5","article-title":"Genome-wide association meta-analysis identifies 29 new acne susceptibility loci.","volume":"13","author":"Mitchell","year":"2022","journal-title":"Nat Commun"},{"issue":"1","key":"hoi240051r42","doi-asserted-by":"publisher","first-page":"6172","DOI":"10.1038\/s41467-023-41180-2","article-title":"European and multiancestry genome-wide association meta-analysis of atopic dermatitis highlights importance of systemic immune regulation.","volume":"14","author":"Budu-Aggrey","year":"2023","journal-title":"Nat Commun"},{"issue":"1","key":"hoi240051r43","doi-asserted-by":"publisher","first-page":"1776","DOI":"10.1038\/s41467-020-15649-3","article-title":"Genome-wide analysis highlights contribution of immune system pathways to the genetic architecture of asthma.","volume":"11","author":"Han","year":"2020","journal-title":"Nat Commun"},{"issue":"4","key":"hoi240051r44","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/ng.543","article-title":"Multiple common variants for celiac disease influencing immune gene expression.","volume":"42","author":"Dubois","year":"2010","journal-title":"Nat Genet"},{"issue":"2","key":"hoi240051r45","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1038\/ng.3760","article-title":"Genome-wide association study implicates immune activation of multiple integrin genes in inflammatory bowel disease.","volume":"49","author":"de Lange","year":"2017","journal-title":"Nat Genet"},{"issue":"6460","key":"hoi240051r46","doi-asserted-by":"publisher","DOI":"10.1126\/science.aav7188","article-title":"Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility.","volume":"365","author":"International Multiple Sclerosis Consortium","year":"2019","journal-title":"Science"},{"issue":"7488","key":"hoi240051r47","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1038\/nature12873","article-title":"Genetics of rheumatoid arthritis contributes to biology and drug discovery.","volume":"506","author":"Okada","year":"2014","journal-title":"Nature"},{"issue":"3","key":"hoi240051r48","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1093\/ije\/dyr036","article-title":"Avoiding bias from weak instruments in mendelian randomization studies.","volume":"40","author":"Burgess","year":"2011","journal-title":"Int J Epidemiol"},{"issue":"2","key":"hoi240051r49","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1093\/ije\/dyv080","article-title":"Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression.","volume":"44","author":"Bowden","year":"2015","journal-title":"Int J Epidemiol"},{"issue":"4","key":"hoi240051r50","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1002\/gepi.21965","article-title":"Consistent estimation in mendelian randomization with some invalid instruments using a weighted median estimator.","volume":"40","author":"Bowden","year":"2016","journal-title":"Genet Epidemiol"},{"issue":"11","key":"hoi240051r51","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1007081","article-title":"Orienting the causal relationship between imprecisely measured traits using GWAS summary data.","volume":"13","author":"Hemani","year":"2017","journal-title":"PLoS Genet"},{"issue":"9","key":"hoi240051r52","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0222362","article-title":"Robust methods in mendelian randomization via penalization of heterogeneous causal estimates.","volume":"14","author":"Rees","year":"2019","journal-title":"PLoS One"},{"issue":"25","key":"hoi240051r53","doi-asserted-by":"publisher","first-page":"5434","DOI":"10.1002\/sim.9133","article-title":"Testing and correcting for weak and pleiotropic instruments in 2-sample multivariable mendelian randomization.","volume":"40","author":"Sanderson","year":"2021","journal-title":"Stat Med"},{"key":"hoi240051r54","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.34408","article-title":"The MR-Base platform supports systematic causal inference across the human phenome.","volume":"7","author":"Hemani","year":"2018","journal-title":"Elife"},{"issue":"4","key":"hoi240051r55","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.ijwd.2019.05.003","article-title":"Sex differences in the prevalence of vascular disease and risk factors in young hospitalized patients with psoriasis.","volume":"5","author":"Garshick","year":"2019","journal-title":"Int J Womens Dermatol"},{"issue":"4","key":"hoi240051r56","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1111\/jdv.16029","article-title":"Psoriasis, cardiovascular risk factors, and metabolic disorders: sex-specific findings of a population-based study.","volume":"34","author":"Sondermann","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"3","key":"hoi240051r57","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1093\/ije\/dyab208","article-title":"Interpreting mendelian-randomization estimates of the effects of categorical exposures such as disease status and educational attainment.","volume":"51","author":"Howe","year":"2022","journal-title":"Int J Epidemiol"},{"issue":"3","key":"hoi240051r58","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1002\/gepi.22376","article-title":"Mendelian randomization with coarsened exposures.","volume":"45","author":"Tudball","year":"2021","journal-title":"Genet Epidemiol"},{"issue":"1","key":"hoi240051r59","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002739","article-title":"Evidence of a causal relationship between body mass index and psoriasis: a mendelian randomization study.","volume":"16","author":"Budu-Aggrey","year":"2019","journal-title":"PLoS Med"},{"issue":"11","key":"hoi240051r60","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1111\/1346-8138.16910","article-title":"Genetic insights into the risk of metabolic syndrome and its components on psoriasis: a bidirectional mendelian randomization.","volume":"50","author":"Liu","year":"2023","journal-title":"J Dermatol"},{"issue":"5","key":"hoi240051r61","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1111\/j.1365-2133.1995.tb02753.x","article-title":"Age at onset and different types of psoriasis.","volume":"133","author":"Swanbeck","year":"1995","journal-title":"Br J Dermatol"},{"issue":"10","key":"hoi240051r62","first-page":"972","article-title":"Coronary artery atherosclerosis revisited in Korean war combat casualties.","volume":"111","author":"Virmani","year":"1987","journal-title":"Arch Pathol Lab Med"},{"issue":"2","key":"hoi240051r63","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1080\/pdp.21.2.213.237","article-title":"Natural history and risk factors of atherosclerosis in children and youth: the PDAY study.","volume":"21","author":"Zieske","year":"2002","journal-title":"Pediatr Pathol Mol Med"},{"issue":"12","key":"hoi240051r64","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.3390\/genes11121482","article-title":"Approaching shared pathophysiology in immune-mediated diseases through functional genomics.","volume":"11","author":"Gonz\u00e1lez-Serna","year":"2020","journal-title":"Genes (Basel)"},{"issue":"12","key":"hoi240051r65","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1038\/ng.3985","article-title":"Shared genetic origin of asthma, hay fever, and eczema elucidates allergic disease biology.","volume":"49","author":"Ferreira","year":"2017","journal-title":"Nat Genet"},{"key":"hoi240051r66","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2019.102392","article-title":"An overview of autoantibodies in rheumatoid arthritis.","volume":"110","author":"van Delft","year":"2020","journal-title":"J Autoimmun"},{"issue":"10","key":"hoi240051r67","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1002\/art.42239","article-title":"Genetic liability to rheumatoid arthritis in relation to coronary artery disease and stroke risk.","volume":"74","author":"Yuan","year":"2022","journal-title":"Arthritis Rheumatol"},{"key":"hoi240051r68","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1095622","article-title":"Impact of ankylosing spondylitis on stroke limited to specific subtypes: evidence from mendelian randomization study.","volume":"13","author":"Mei","year":"2023","journal-title":"Front Immunol"},{"key":"hoi240051r69","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2022.103501","article-title":"Myocardial infarction and stroke risks in multiple sclerosis patients: a 2-sample mendelian randomization study.","volume":"58","author":"Peng","year":"2022","journal-title":"Mult Scler Relat Disord"},{"issue":"3","key":"hoi240051r70","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1097\/01.ede.0000215160.88317.cb","article-title":"Instrumental variables: application and limitations.","volume":"17","author":"Martens","year":"2006","journal-title":"Epidemiology"},{"issue":"1","key":"hoi240051r71","doi-asserted-by":"publisher","first-page":"137","DOI":"10.3109\/14397595.2016.1174328","article-title":"Serum interleukin-6 levels in response to biologic treatment in patients with psoriasis.","volume":"27","author":"Muramatsu","year":"2017","journal-title":"Mod Rheumatol"},{"issue":"1","key":"hoi240051r72","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s00281-015-0539-8","article-title":"Update on psoriasis immunopathogenesis and targeted immunotherapy.","volume":"38","author":"Mahil","year":"2016","journal-title":"Semin Immunopathol"},{"key":"hoi240051r30","doi-asserted-by":"crossref","unstructured":"Dand? N, Stuart? PE, Bowes? J, . GWAS meta-analysis of psoriasis identifies new susceptibility alleles impacting disease mechanisms and therapeutic targets.? medRxiv. 2023;doi:10.1101\/2023.10.04.23296543","DOI":"10.1101\/2023.10.04.23296543"}],"container-title":["JAMA Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamacardiology\/articlepdf\/2823895\/jamacardiology_ramessur_2024_oi_240051_1730392577.06014.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,13]],"date-time":"2024-11-13T11:39:05Z","timestamp":1731497945000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamacardiology\/fullarticle\/2823895"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,1]]},"references-count":72,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,11,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamacardio.2024.2859","relation":{},"ISSN":["2380-6583"],"issn-type":[{"value":"2380-6583","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11,1]]}}}